| Financial Year |
March 31 2023 |
| Monetary Funds |
1,600,797,886.39 |
| Held-for-trading Financial Assets |
742,831,834.25 |
| Notes Receivable |
53,675,518.02 |
| Accounts Receivable |
408,653,573.71 |
| Advances to Suppliers |
92,394,526.88 |
| Other Receivables |
8,374,739.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
880,812,215.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,000,000.00 |
| Other Current Assets |
45,321,703.83 |
| Total Current Assets |
3,860,268,262.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
834,893.75 |
| Fixed Assetes |
490,545,102.80 |
| Under-construction Projects |
21,529,486.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,526,145.90 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
353,822.96 |
| Deferred Income Tax Assets |
49,556,389.82 |
| Other Non-Current Assets |
100,004,520.00 |
| Sub-Total of Non-Current Assets |
820,620,594.55 |
| Total Assets |
4,680,888,857.29 |
| Short-Term Loans |
125,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,649,555.50 |
| Accounts Payable |
118,053,817.96 |
| Accounts Received In Advance |
600,680.23 |
| Employee Compensation Payable |
15,540,716.93 |
| Taxes Payable |
26,955,263.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,780,755.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
300,000,000.00 |
| Other Current Liabilities |
61,304,273.98 |
| Sub-Total of Current Liabilities |
1,066,162,497.29 |
| Long-term Loans |
106,138,781.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,451,541.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
200,691,920.08 |
| Total Liabilities |
1,266,854,417.37 |
| Paid-In Capital(Or Share Stock) |
959,400,000.00 |
| Capital Surplus |
1,384,006,042.22 |
| Surplus Reserve |
117,722,322.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
853,983,838.72 |
| Minority Stockholder's Interest |
98,922,236.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,315,112,203.06 |
| Owner's Equity（Stockholder's Equity） |
3,414,034,439.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,680,888,857.29 |
